CHRU is participating in ‘A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated Covid-19 in Adult Participants’.
It is called the Ensemble study. The main pharmaceutical company involved in the study is Janssen, which is owned by Johnson and Johnson. This is the first Phase 3 COVID-19 vaccine trial to be conducted in South Africa.
The purpose of this clinical research study is to determine whether the vaccine works to prevent COVID-19 and whether it is safe for a large population of people. The vaccine is being evaluated in people 18 years of age or older.